Nonclinical and Clinical Pharmacology Evidence for Cardiovascular Safety of Saxagliptin

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-017-0595-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Pharmacology and Pharmacoepidemiology for Medication Safety in Clinical Settings

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2015English

Lamotrigine: Pharmacology, Clinical Utility, and New Safety Concerns

American Journal of Psychiatry Residents' Journal
2018English

Review Article: Nonclinical and Clinical Pharmacology, Pharmacokinetics and Pharmacodynamics of Etrolizumab, an Anti-Β7 Integrin Therapy for Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Cardiovascular Pharmacology

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2014English

Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease

Clinical Medicine Insights: Cardiology
Cardiovascular MedicineCardiology
2012English

Nonclinical Safety Assessment for the Sensitizing Potential of K-115

Fundamental Toxicological Sciences
2014English

Clinical Pharmacology.

Annals of Internal Medicine
Internal MedicineMedicine
1979English

Clinical Pharmacology

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

The Cardiovascular Physiology and Pharmacology of Endothelin-1

Advances in Pharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy